Single treatment of rats with the noncompetitive N-methyl-D-aspartate receptor antagonist MK-801 induces neuronal cell degeneration and death in the retrosplenial/posterior cingulate cortex (RS/PC) region, along with local cerebral glucose utilization. However, the relationship between this neuronal cell degeneration and death and glucose utilization remains unclear. To investigate the mechanism of MK-801-induced neurotoxicity and its relation to glucose utilization, changes in endogenous metabolites in the RS/PC region of MK-801 treated rats were assessed using metabolomics. Inverse correlation between citrulline and arginine levels suggested increased nitric oxide (NO) production. In addition, decreased levels of purine metabolites suggested enhanced xanthine oxidase activity accompanied with reactive oxygen species (ROS) production. Histopathological analysis confirmed that the production of ROS in the RS/PC region was increased by MK-801 and that the nonspecific NO synthase inhibitor Nx-nitro-L-arginine methyl ester (L-NAME) prevented MK-801-induced neuronal cell death. These results suggest that NO increases oxidative stress-related cell death. Increased levels of metabolites of glucose metabolism suggested enhanced energy production via glycolysis. To confirm the relationship between NO and glucose utilization, positron emission tomography (PET) imaging with L-NAME ameliorated MK-801-induced glucose utilization.In conclusion, MK-801 induces NO and ROS production in the RS/ PC region, which might subsequently induce oxidative stress and in turn neuronal cell death. In addition, MK-801-induced NO production increased glucose utilization and affected glucose metabolism, the imbalance of which might generate additional oxidative stress related to neuronal cell death.
N-methyl-D-aspartate (NMDA) receptor antagonists exert neuroprotective effects in various experimental models of focal ischemia (Church et al., 1988; Collins and Olney, 1982; Gill et al., 1991) . These antagonists, however, also induce neurotoxicity in specific areas of the brain in adult rats. A single treatment of NMDA receptor antagonists induces neuronal degeneration characterized by vacuolar changes in the retrosplenial/posterior cingulate cortex (RS/PC) region (Carliss et al., 2007; Fix et al., 1993 Fix et al., , 1996 Olney et al., 1989) . MK-801 is a noncompetitive blocker of the open ion channel of the NMDA receptor and one of the most neurotoxic NMDA receptor antagonists (Olney et al., 1989) and was reported to induce the neuronal cell vacuolation in the rat RS/PC region at 4-h posttreatment (Fix et al., 1996; Hashimoto et al., 2000; Olney et al., 1989) . MK-801-induced vacuolar changes then disappeared, and neuronal cell death was detected in the same region at 24 h (Fix et al., 1993; Shirakawa et al., 2013) . To our knowledge, however, the mechanism of MK-801-induced vacuolar changes is not fully understood, and few reports have described the relationship between vacuolar change and cell death in adult rats.
MK-801 induces marked regional alterations in local cerebral glucose utilization in rats Nehls et al., 1990; Sharkey et al., 1994) . Post-MK-801 treatment, this alteration was observed during the early phase along with neuronal vacuolar changes, and glucose utilization was detected in areas closely similar to those with MK-801-induced pathological changes. Our previous report using positron emission tomography (PET) imaging with [ 18 F] fluoro-2-deoxy-D-glucose ([ 18 F] FDG) demonstrated that MK-801-induced alteration of glucose utilization was closely related to neurotoxicity (Shirakawa et al., 2013) . [
18 F] FDG accumulation was detected in the rat RS/PC region in which vacuolar changes occurred. Further, in cynomolgus monkeys, no neuronal cell degeneration or cell death was observed in the posterior cingulate cortex, and alteration of [ 18 F] FDG accumulation was not detected in any region of the brain. However, the relationship between glucose utilization and MK-801-induced neurotoxicity remains unclear.
"Metabolomics" is a rapidly evolving technology that uses highly sensitive analytical methods to comprehensively analyze endogenous metabolites in samples and characterize the mechanisms of physiological events (Robertson et al., 2011) . Although metabolomics is also used in toxicological studies, few studies have used this approach to analyze neurotoxicity.
Here, we used metabolomics for the comprehensive assessment of changes in levels of metabolites in the RS/PC region of MK-801-treated rats. Histopathological examination was conducted to verify the results of metabolomics analyses. We then used [
18 F] FDG-PET to confirm the relationship of glucose utilization to MK-801-induced nitric oxide (NO) production and clarify how glucose metabolism relates to the pathway of MK-801-induced neuronal cell death.
MATERIALS AND METHODS
Animals. Female rats are reportedly more sensitive to MK-801-induced neurotoxicity than male rats (Auer, 1996; JevtovicTodorovic et al., 2001) . In this study, we used female rats to investigate the relationship between neuronal cell death and glucose utilization detected by [
18 F] FDG-PET imaging as previous reported (Shirakawa et al., 2013) . Female Sprague Dawley rats (Crl: CD [SD]) aged 11-weeks were purchased from Charles River Laboratories Japan, Inc. Animals were acclimatized for 3-7 days prior to experiments. Room temperature was maintained at 23 C 6 3 C with a relative humidity of 55% 6 5% and light provided from 07:00 to 19:00. Animals were allowed ad libitum access to a pellet diet (CRF-1; Oriental Yeast, Co, Ltd, Tokyo, Japan) and microfiltered tap water. All animal experiments were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals of Astellas Pharma Inc. The Kashima and Tsukuba facilities of Astellas Pharma Inc are accredited by AAALAC International.
Animal treatment. A single dose of MK-801 maleate (Wako Pure Chemical Industries, Ltd, Osaka, Japan) dissolved in physiological saline was subcutaneously administered at 1 mg/kg as the minimum dose at which both neuronal degeneration and neuronal cell death could be detected by 24 h. The vehicle control group was treated in a similar manner with physiological saline alone. Nx-nitro-L-arginine methyl ester (L-NAME; Wako Pure Chemical Industries, Ltd) dissolved in physiological saline was administrated intraperitoneally. For histopathological examination, given that ex vivo NOS activity disappeared by 6 h postadministration in brain tissue (Salter et al., 1995) , L-NAME was administered at 60 mg/kg as follows: 30 min pre-and 4 and 8 h post-MK-801 treatment. For the PET study, L-NAME was administered once at 60 mg/kg at 30 min pre-MK-801 treatment.
Metabolomics. Rats (n ¼ 3 animals/group) were anesthetized with isoflurane (Mylan Inc, Canonsburg, Pennsylvania) at 4 h post-MK-801 treatment. Rats then underwent transcardial perfusion with saline and then brain removal. Tissue from the RS/PC region was separated from the whole brain, frozen in liquid nitrogen, and stored at À80 C until analysis.
Frozen brain samples were weighed and immersed into 1000 ml of methanol (132-14524, Wako) containing internal standards (H3304-1002; Human Metabolome Technologies, Inc [HMT] , Tsuruoka, Japan) on ice to inactivate enzymes prior to measurement by capillary electrophoresis time-of-flight mass spectrometry (CE-TOF MS). Samples were homogenized at 1100 Â g for 10 min using a Shake Master (Bio Medical Science Inc, Tokyo, Japan). After the homogenate was mixed with 400 ml of Milli-Q water and 1000 ml of chloroform (034-02603, Wako) by using vortex mixer, the homogenate was centrifuged at 2900 Â g at 4 C for 20 min. Subsequently, 700 ml of upper aqueous layer was centrifugally filtered through a Millipore 5-kDa cutoff filter (UFC3LCCNB-HMT, HMT) at 9100 Â g at 4 C overnight to remove proteins. The filtrate was evaporated and resuspended in 50 ml of Milli-Q water containing internal standards (H3304-1004, HMT) for CE-TOF MS analysis. CE-TOF MS was conducted using Agilent Capillary Electrophoresis System (Agilent Technologies, Santa Clara, California) equipped with an Agilent 6224 TOF mass spectrometer (Agilent Technologies). The system was controlled by Agilent ChemStation software (G1601BA, version B.04.03; Agilent Technologies). Cationic metabolite levels were analyzed using a commercial fused silica capillary (H3305-1002, HMT; 50 mm i.d. Â 80 cm total length) with commercial electrophoresis buffer (H3301-1001, HMT) as the electrolyte, and a commercial sheath liquid (H3301-1020, HMT) was delivered at a rate of 10 ml/ min. Approximately 10 nl of sample solution was injected at a pressure of 50 mbar for 10 s, and applied voltage was set at 27 kV. Electrospray ionization TOF MS (ESI-TOF MS; Agilent Technologies) was operated in the positive ion mode, and capillary and fragmenter voltage were set at 4000 and 110 V. A flow rate of heated dry N 2 gas (heater temperature, 300 C) was maintained at 5 psig and 7 l/min. Spectrometer was scanned from m/ z 50 to 1000. Anionic metabolites were analyzed using a commercial fused silica capillary (H3305-1002, HMT; 50 mm i.d. Â 80 cm total length), with commercial electrophoresis buffer (H3302-1021, HMT) as the electrolyte, and a commercial sheath liquid (H3301-1020, HMT) was delivered at a rate of 10 ml/ min. Approximately 25 nl of sample solution was injected at a pressure of 50 mbar for 25 s, and applied voltage was 30 kV. ESI-TOF MS was operated in the negative ion mode, and capillary and fragmenter voltage were set at 3500 and 125 V. A flow rate of heated dry N 2 gas (heater temperature, 300 C) was maintained at 5 psig and 7 l/min. The spectrometer was scanned from m/z 50 to 1000. Other conditions were as previously described (Soga and Heiger, 2000; Soga et al., 2002 Soga et al., , 2003 . Data processing of MS was conducted as follows. Peaks were extracted using MasterHands automatic integration software (Keio University, Tsuruoka, Japan) to obtain peak information including m/z, migration time (MT), and peak area KURODA ET AL. | 345 (Sugimoto et al., 2010) . Signal peaks corresponding to isotopomers, adduct ions, and other product ions of known metabolites were excluded, and remaining peaks were annotated with putative metabolites from the MasterHands database based on their MTs and m/z values. The tolerance range for the peak annotation was configured at 60.2 min for MT and 640 ppm for m/z. In addition, peak areas were normalized against those of the internal standards and values of relative areas were further normalized by tissue weight.
Detection of reactive oxygen species production. Dihydroethidium (DHE; Sigma Aldrich Inc, Tokyo, Japan) was dissolved in physiological saline containing 1% dimethyl sulfoxide (Sigma Aldrich Inc) and 0.1% sodium chloride (Wako Pure Chemical Industries, Ltd) to prepare a 1 mg/ml solution. At 2 h post-MK-801 treatment, rats (n ¼ 6 animals/group) received DHE solution intravenously via the tail vain. Rats were then anesthetized with isoflurane inhalation 2 h post-DHE treatment and transcardialy perfused with saline. The brain was quickly removed and frozen in liquid nitrogen. The frozen brain tissue was cut into 14-mm sections and examined using a fluorescent microscope (Olympus, Tokyo, Japan) with excitation at 510 nm and emission 590 nm to detect oxidized DHE. The fluorescence intensity of each cell in the area corresponding to RS/PC region was measured using Cell Sens imaging software (Olympus), and the sum of fluorescence intensity of each cell was evaluated as an indicator of reactive oxygen species (ROS) production.
Histopathological examination. At 24 h post-MK-801 treatment, rats (n ¼ 5 animals/group) were anesthetized with isoflurane inhalation and received a transcardial perfusion with saline for a short period, and then with 10% formaldehyde neutral buffer solution (Sigma Aldrich Inc) as a fixative. Perfused brains were quickly removed and immersed in the same fixative overnight, and then embedded in paraffin and cut into 4-mm sections with a microtome. Specimens were stained with hematoxylin and eosin (H&E) and histopathologically examined (1 section/animal). Neuronal vacuolation characterized by intracytoplamic fine vacuole formation and neuronal cell death characterized by shrinkage of the cell body, intense staining of eosinophilic cytoplasm, and shrinkage and dark staining of pyknotic nucleus were assessed, and the degree of changes was categorized as "absent or slightly present (À)" or "distinctly present (þ After 50 min of uptake, rats were anesthetized (isoflurane 2.0%-2.5% in 100% oxygen gas), spread in prone position, and placed with their head centered in the field of view. A 5-min static acquisition was taken from 60 min after [ 18 F] FDG injection in the 3-dimensional (3D) mode. All images were reconstructed using the 3D Ordered Subset Expectation Maximization algorithm with dead time decay random and scatter corrections applied. After PET acquisition, rats were sacrificed, and blood was collected. Blood samples were weighed and measured for radioactivity using a c-counter (Wallac 2480; Perkin Elmer, Waltham, Massachusetts). Data obtained from the brain and blood in units of Bq/g were converted to a standardized uptake value (SUV) using the following equation:
injected radioactivity per body weight Bq=g ½ ð Þ Given that SUV [blood] was affected by drug treatment, SUV [brain] was divided by the SUV [blood] of the same animal. Representative PET images were shown in Figure 5A with normalized SUV [brain] value.
Statistical analysis. Metabolomics data were analyzed using Microsoft Excel 2010 (Microsoft Corporation, Redmond, Washington). Data were presented as mean value 6 standard error of the mean (SEM), and analyzed using Student's t test to compare metabolite levels between the control and MK-801-treated groups. P values < .05 were considered significant. Multiple comparisons were made using the false discovery rate (FDR) method to improve statistical robustness. A cutoff value of q < 0.2 for the FDR was applied in accordance with previous metabolomics studies (Chen et al., 2014; Fiehn et al., 2010; Putluri et al., 2011; Wei et al., 2013) .
Other quantitative data were analyzed using GraphPad Prism 5 (GraphPad Software, Inc, San Diego, California). Data were presented as the mean value 6 SEM and analyzed using the F test for analysis of variance, followed by Student's or Welch's t test. P values < 0.05 were considered to be significant.
RESULTS

Metabolomic Analysis of RS/PC Region in MK-801-Treated Rats
Changes in levels of metabolites were comprehensively analyzed in the tissues of RS/PC region of animals at 4-h posttreatment with saline or 1 mg/kg of MK-801. Analysis with a CE-TOF MS system in cation and anion modes detected 366 peaks in RS/ PC region tissue. Of these, 253 were identified and quantified with metabolite standards matching the closest m/z values and normalized MT for further statistical comparison and interpretation using the CE-TOF MS system. The identified metabolites and their quantities are listed in Supplementary Table 1 . Although additional unidentified analytes were observed, only the identified metabolites in this study are discussed. Table 1 shows metabolites with statistically significant changes in levels between the control and MK-801 treated groups. Major pathways involving these markedly changed metabolites were glucose metabolism and the urea cycle. Levels of glycolysis metabolites, including glucose-6-phosphate, fructose-6-phosphate, fructose-1, 6-bisphosphate, and 3-phosphoglycerate were markedly increased in the MK-801-treated group (Fig. 1) . The TCA cycle was also affected by MK-801, with a significant increase malate levels and a tendency toward increases in succinate and fumarate levels. In the urea cycle, MK-801 significantly decreased arginine levels and tended to increase citrulline levels (Fig. 2) . Arginine consumption is considered to depend on arginase and NOS activities. Results showed no notable changes in ornithine levels, and citrulline-to-ornithine ratio increased 3.5-6.5 post-MK-801 treatment, suggesting that increased arginine consumption was due to the activity of NO synthase and not arginase.
In purine degradation pathway, levels of inositol monophosphate and hypoxanthine significantly decreased (Table 1) , and those of xanthine, inosine, adenine, and adenosine tended to decrease (Supplementary Table 1) in the MK-801-treated group.
Effects of MK-801 on ROS Production in RS/PC Region
Given that metabolomics revealed enhancement of glucose metabolism, NO production, and purine degradation, the effects of MK-801 on ROS production were investigated using DHE as its oxidation by ROS produces red fluorescence. To evaluate quantitative ROS production, oxidized DHE fluorescence intensity in the RS/PC region was measured by image analysis. Fluorescence intensity in the RS/PC region was significantly increased by MK-801 treatment, which indicates that MK-801 increased ROS production in this region (Figs. 3A and 3B ). In the other brain regions, no obvious increase in fluorescence intensity was detected on microscopic observation.
Effects of L-NAME on the Neuronal Cell Death Induced by MK-801 Based on the findings of metabolomics, the involvement of NO in MK-801-induced neuronal cell death in the RS/PC region in rats was investigated. Morphological changes in the RS/PC region following cotreatment with the nonselective NO synthase inhibitor L-NAME and MK-801 were histopathologically assessed. Figure 4A shows representative images of the RS/PC region in rats at 24 h post-MK-801 treatment at 1 mg/kg alone with neuronal cell death. Although cotreatment of L-NAME with MK-801 suppressed neuronal cell death, vacuolar changes were detected ( Fig. 4B and Table 2 ). In contrast, these changes were not detected at 24 h post-MK-801 treatment alone (Fig. 4A and Table 2 ). No changes in neuronal cells were detected with L-NAME treatment alone (Fig. 4C) .
Effects of L-NAME on the Increased Glucose Utilization Induced by MK-801
We previously reported that [
18 F] FDG-PET enabled the detection of MK-801-induced glucose utilization in the RS/PC region (Shirakawa et al., 2013) . To investigate the involvement of NO production in MK-801-induced glucose utilization in the RS/PC region of rats, [
18 F] FDG-PET imaging was conducted 2 h after treatment with MK-801 and L-NAME. As L-NAME is reported to alter total body fluid and because SUV [blood] (Fig. 5A) , as previously reported (Shirakawa et al., 2013) . On comparing the normalized values of SUV [RS/PC] /SUV [blood] , cotreatment with L-NAME at 60 mg/kg significantly decreased MK-801-induced [ 18 F] FDG accumulation (Fig. 5B) . In our previous study, we confirmed that [ 18 F] FDG accumulation was not detected in any region of brain by saline treatment (Shirakawa et al., 2013) .
DISCUSSION
In this study, metabolomics was conducted to provide information on metabolites relating to the mechanisms of MK-801-induced neurotoxicity. Given the findings of metabolomics suggesting enhancement of glycolysis, NO production, and purine KURODA ET AL. | 347 degradation in the RS/PC region post-MK-801 treatment, we focused on the potential for NO to cause oxidative stress-related cell death. MK-801-induced ROS production in the RS/PC region was confirmed, and the NO synthase inhibitor L-NAME prevented MK-801-induced neuronal cell death. These results suggest that NO is a primary factor of neuronal cell death caused by oxidative stress. In addition, metabolomics also identified changes in glucose metabolism. To investigate the relationship between glucose metabolism and NO production, we performed [
18 F] FDG-PET imaging posttreatment with L-NAME and MK-801. L-NAME reduced MK-801-induced glucose utilization, indicating that MK-801-induced glucose utilization and neuronal cell death were NO-triggered serial changes.
We previously reported that [ 18 F] FDG-PET detects MK-801-induced glucose utilization induced by MK-801 (Shirakawa et al., 2013) . [ 18 F] FDG accumulation increased before the appearance of neuronal vacuolation, which is known to occur before cell death. However, no clear correlation was confirmed between glucose utilization and neuronal cell death. We therefore assessed changes in metabolite levels in the RS/PC region of MK-801-treated rats using metabolomics. Results showed increases in levels of metabolites of glycolysis and the TCA cycle (Fig. 1) , alterations in arginine and citrulline levels, which suggested increased NO production (Fig. 2) , and decreases in levels of metabolites in purine degradation pathway (Supplementary Table 1) . cate statistically significant changes (*P < .05 and q < 0.2), and hollow arrows indicate suggestive changes, with a nonsignificant trend with a fold change (MK-801 vs vehicle control) >1.2 or <0.8. RA, relative amount; Glc, Glucose; Glu1P, Glucose-1-phosphate; Glu6P, Glucose-6-phosphate; Frc6P, Fructose-6-phosphate; Frc-1,6-P, Fructose-1,6-bisphosphate; GAP, 3-P-Glyceraldehyde; DHAP, Dihydroxyacetone phosphate; 3-BPG, 1,3-bisphosphoglycerate; 3PG, 3-Phosphoglycerate; 2PG, 2-phosphoglycerate; PEP, Phosphoenol pyruvate; Pyr, pyruvate; SucCoA, Succinyl CoA 
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We first focused on the inverse association between arginine and citrulline levels, in which a decrease in the former results in an increase in the latter. In addition, the citrulline-to-ornithine ratio increased post-MK-801 treatment (Fig. 2) , suggesting that decreases in arginine levels were due to increases in NOS activity rather than arginase activity. These results also suggest an increase in NO production.
A number of reports have been published regarding the relationship between MK-801-induced neuronal cell death and oxidative stress. In the prefrontal cortex, multiple MK-801 treatments induced neuronal cell death with increased expression of oxidative stress markers, which was reduced by antioxidants such as free radical scavengers (dimethyl sulfoxide [DMSO] and a-tocopherol), spin traps, or x-3 fatty acids (Ozyurt et al., 2007b; Willis and Ray, 2007) . Single treatment of MK-801to mice increased hydroxyl radical levels in the RS/PC region (Zuo et al., 2007) .
The respiratory chain of mitochondria is a major source of ROS such as O À 2 and H 2 O 2 . Further, ROS generation might be induced by NO, which has the potential to inhibit complex IV in the respiratory chain (Heales et al., 1999) . Results of metabolomics showed decreased levels of xanthine and hypoxanthine. Ozyurt et al. (2007a) reported multiple treatment of MK-801 increased xanthine oxidase (XO) activity in rat tissue of frontal cortex. The decreases in levels of xanthine and hypoxanthine may be attributable to an increase in XO activity. XO has been proposed as ROS producer (Harrison, 2004) . MK-801 might contribute to ROS generation by XO.
We therefore investigated the effect of MK-801 on ROS production in RS/PC region using DHE. As a result, MK-801 increased fluorescence intensity via oxidized DHE in the RS/PC region (Fig. 3) . DHE is oxidized by ROS resulting in generation of 2 products, ethidium and 2-hydrxyethidium, both of which bind to nuclear DNA and form a red fluorescent complex (Parfenova et al., 2012) . 2-Hydroxyethidium is a product of DHE oxidation by superoxide, whereas ethidium is also detected as an H 2 O 2 -related product (Bindokas et al., 1996; Zhao et al., 2005) . Recent in vivo studies in mice with genetically altered expression of superoxide dismutase demonstrated that oxidized DHE fluorescence quantitatively correlates to superoxide levels in the brain (Hall et al., 2012) . We therefore measured the total fluorescence from oxidized DHE, including 2-hydroxyethidium and ethidium, as an indicator of ROS production. This was considered to indicate levels of superoxide and, to a lesser extent, H 2 O 2 . Increased fluorescence from oxidized DHE reflected ROS production in the RS/PC region of MK-801-treated rats. Excessive O À 2 , which is an ROS generated in mitochondria or purine degradation, might be a source of cytotoxic hydroxyl radical. Zuo et al. (2007) reported that hydroxyl radical was generated in the RS/PC region of MK-801-treated mice. In addition, NO reacts with O À 2 and generates cytotoxic peroxynitrite anion (ONOO À ), which is considered a mechanism of NO-induced cytotoxicity (Lipton et al., 1993) . MK-801-induced cell death might therefore be due to hydroxyl radical and ONOO À ( Supplementary Fig. 1 ).
To investigate whether NO is a primary factor for MK-801-induced neuronal cell death, we performed histopathological examination using the NOS inhibitor L-NAME. This inhibitor reduced the rates of neuronal cell death at 24 h post-MK-801 treatment (Fig. 4) , which demonstrates that MK-801 induces NO, and in turn induces neuronal cell death.
L-NAME did not completely eliminate neuronal vacuolation (Fig. 4 and Table 2 ). Single treatment of MK-801 alone at 1 mg/kg induced neuronal vacuolar changes at 4 h (Hashimoto et al., 2000; Olney et al., 1989) . These vacuolar changes disappeared, and neuronal cell death appeared at 24 h (Fix et al., 1993; Shirakawa et al., 2013) . MK-801 has a high affinity for NMDA receptors and has long-lasting pharmacological action (Kato, 2004) . In contrast, L-NAME has a brief duration of inhibition against NOS activity (Salter et al., 1995) . Vacuolar changes observed following cotreatment with L-NAME are therefore considered to be the persistent action of MK-801 following the disappearance of L-NAME-induced inhibition and to reflect the duration of pharmacological action of MK-801 and L-NAME.
Results of metabolomics also revealed the changes in glucose metabolism. Increased glucose utilization was confirmed to be the result of increased glucose-6 phosphate the first metabolite in glycolysis (Fig. 1) . This result is consistent with previous reports that MK-801 increased glucose utilization detected by [ 18 F] FDG-PET (Shirakawa et al., 2013) and autoradiography . This study also demonstrates increased levels of other metabolites of glycolysis including lactate. These changes in metabolite levels indicate the possibility of enhanced energy production by glycolysis and lactic fermentation.
NO decreases ATP production in the respiratory chain via inhibition of complex IV, resulting in enhanced glycolysis and lactate fermentation to compensate for the reduced energy production in the respiratory chain (Heales et al., 1999) . NO might therefore increase glucose utilization, reflecting enhanced glycolysis and lactate fermentation ( Supplementary Fig. 1 ). In this study, we could not assess accurate levels of ATP, because the peaks of ATP could not be separated in metabolomics, and measurement of ATP in brain tissue is generally difficult due to the instability (Hattori et al., 2010) .
We next investigated whether NO increased glucose utilization. [ Table 2 ). MK-801-induced neurotoxicity is known to be caused by excessive glutamate release from cholinergic neurons projecting into the RS/PC region, and this increased glucose utilization might therefore be a result from neuronal overactivation in the RS/PC region Patel and McCulloch, 1995) . In this study, however, [ 18 F] FDG-PET indicated that increased glucose utilization was eliminated via inhibition of NO production (Fig. 5) . MK-801-induced glucose utilization might therefore be attributable to NO, rather than enhanced neuronal activity.
Enhanced glycolysis might increase the levels of metabolites entering the TCA cycle. Notably, MK-801 increased levels of succinate, fumarate, and malate. Succinate has been reported to cause ROS generation at complex I in isolated rat brain mitochondria (Zoccarato et al., 2009) . Further, the injection of succinate into mouse brain has been shown to increase the expression of oxidative stress markers (Sinhorin et al., 2005) . In isolated rat brain mitochondria, complex IV inhibitors such as NO, CO, or cyanide (CN À ) were reported to render mitochondria more sensitive to succinate-induced ROS production (Zoccarato et al., 2009) . Therefore, succinate might cause further ROS KURODA ET AL. | 351 generation from the respiratory chain via colocalization with NO ( Supplementary Fig. 1 ).
In conclusion, metabolomics demonstrated that MK-801 enhanced glucose metabolism, NO production, and purine degradation in the RS/PC region of rat brains. MK-801 also induced ROS generation in the RS/PC region. These results suggest that MK-801-induced cell death occurred due to oxidative stress. The relation of NO production to cell death was verified by histopathological assessment. In addition, we demonstrated that NO caused an increase in glucose utilization by [ 18 F] FDG-PET. NO might act as an inhibitor of oxidative phosphorylation in the respiratory chain to increase ROS production, resulting in oxidative damage and an increase in glucose utilization. Further, in cases where these 2 mechanisms occur simultaneously, succinate might accumulate and cause further oxidative damage.
Findings from this study suggest that MK-801 might cause neurotoxicity by inducing NO production. The produced NO might induce oxidative damage via inhibition of respiratory chain and in turn neuronal cell death. ROS generation from purine degradation reaction might contribute oxidative damage. In addition, NO affects glucose metabolism, the imbalance of which might generate additional oxidative stress related to neuronal cell death.
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